rifater tablets
sigma pharmaceuticals plc - pyrazinamide; rifampicin; isoniazid - oral tablet - 300mg ; 120mg ; 50mg
rifater tablets
lexon (uk) ltd - pyrazinamide; rifampicin; isoniazid - oral tablet - 300mg ; 120mg ; 50mg
peteha 250mg tablets
imported (germany) - protionamide - oral tablet - 250mg
doxy-500 ws
interchemie werken 'de adelaar' b.v. - doxycycline (doxycycline hyclate) - powder oral - 500mg/g
limoxin-200la
interchemie werken 'de adelaar' b.v. - oxytetracycline (oxytetracycline dihydrate) - solution for injection - 200mg/ml
macrolan-200 200mg/ml solution for injection
interchemie werken de adelaar b.v. - tylosin (tylosin tartrate) - solution for injection - 200mg/ml
vit-b-denk tablets film-coated
denk pharma gmbh & co. kg - thiamine (thiamine hydrochloride)(vitaminb1), pyridoxine (pyridoxine hydrochloride)(vitaminb6) - tablets film-coated - 100mg+ 200mg
cernevit, powder for solution for injection or infusion
baxter holding b.v. - retinol palmitate; cholecalciferol; dl-a-tocopherol; ascorbic acid; cocarboxylase tetrahydrate; riboflavin sodium phosphate; pyridoxine hydrochloride ; cyanocobalamin; folic acid; dexpanthenol; d-biotin; nicotinamide - powder for solution for injection/infusion - multivitamins, plain
myambutol tablets 100mg
aspen pharma pty ltd - ethambutol hydrochloride, quantity: 100 mg - tablet, film coated - excipient ingredients: sorbitol solution (70 per cent) (non-crystallising); sucrose; gelatin; stearic acid; magnesium stearate; quinoline yellow; purified water; purified talc; shellac; industrial methylated spirit; povidone; acetylated monoglycerides - indications as at 04 jan 2002 : oral administation : myambutol is indicated for the treatment of pulmonary tuberculosis, as shown by a large number of studies by investigators throughout the world. it has also been used successfully in cases of primary tuberculosis and extrapulmonary forms of tuberculosis, including miliary tuberculosis, tuberculois meningitis, tuberculosis of bones and joints, genitourinary tuberculosis, tuberculous of the shin and tuberculous eye diseases. it should not be used as the sole antituberculosis drug, but should be used in conjuction with at least one other antituberculosis drug. selection of the companion drug should be based on clinical experience, considerations of comparative safety and appropriate in vitro susceptibility studies. in patients who have not received previous antituberculosis therapy, i.e. initial treatment, the most frequently used regimens have included three of the following drugs - myambutol, isoniazid, rifampicin and streptomycin - for the first 2-4 mo
rediplex tablet fc
zontron pharmaceuticals sdn. bhd. - calcium pantothenate; thiamine mononitrate; nicotinamide; cyanocobalamin; pyridoxine hcl/vitamin b6; riboflavine -